Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP

This publication has 45 references indexed in Scilit:

• Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine
  Published by Elsevier ,2002
• Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)
  Toxicology Letters, 1989
• MPTP Toxicity: Implications for Research in Parkinson's Disease
  Annual Review of Neuroscience, 1988
• Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicity
  Biochemical and Biophysical Research Communications, 1987
• Biochemistry of the neurotoxic action of MPTP: or how a faulty batch of ‘designer drug’ led to parkinsonism in drug abusers
  Trends in Biochemical Sciences, 1987
• E/Z-equilibria. 11. Structure of a metalated Schiff base
  Journal of the American Chemical Society, 1986
• MPTP
  Neurology, 1986
• Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase B
  FEBS Letters, 1985
• MPTP and parkinson's disease
  Trends in Neurosciences, 1985
• Superoxide-and Ethane-Formation in Subchloroplast Particles: Catalysis by Pyridinium Derivatives
  Zeitschrift für Naturforschung C, 1980